Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
ESMO 2024: Pfizer’s cachexia drug provides meaningful weight gain
Pfizer’s cancer cachexia candidate has provided patients with clinically meaningful weight gain in a Phase II trial, with the company sharing aims to start a pivotal programme in 2025.
Pfizer: Potential cachexia cancer drug shows life-saving promise
A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical tests, drug-maker Pfizer announced Saturday.
Pfizer says its experimental drug for deadly condition that causes appetite and weight loss in cancer patients shows positive trial results
The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for cancer cachexia.
ESMO: Pfizer drug helps cancer patients gain weight
Mid-stage data reported at the ESMO congress in Barcelona showed that ponsegromab was able to increase weight by 5.6% at the most effective dose, above the 5% threshold deemed clinically meaningful, and Pfizer is now thinking about starting a phase 3 programme for the drug next year.
Pfizer drug shows promise in cancer-related condition that causes weight loss and weakness
Pfizer reported at #ESMO that an experimental antibody helped cancer patients with a condition known as cachexia.
New Cancer Drug Boosts Weight, Activity in Patients
Researchers discovered a drug that safely and effectively helped cancer patients when they suffered from cachexia (ku-KEK-see-uh), a common condition
ESMO: Pfizer sees weight gain in cancer patients, aims to enter phase 3 in 2025
Cancer patients with wasting syndrome have gained weight after taking Pfizer’s anti-GDF-15 antibody in a midphase study, emboldening the Big Pharma to target a 2025 start date for its pivotal trial program.
Experimental drug helps cancer patients regain weight, study shows
Pfizer Inc.'s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, offering fresh promise for treating the dangerous muscle-wasting condition.
Pfizer drug helped cancer patients regain weight, study shows
Pfizer Inc.’s experimental drug for cancer weight loss was shown to help patients regain weight in a mid-stage study, offering fresh promise for treating the dangerous muscle-wasting condition. In
Pfizer therapy succeeds in mid-stage trial for cancer-related weight loss
Pfizer's (PFE) experimental therapy for cancer related weight loss, ponsegromab, meets the primary endpoint in Phase 2 trial. Read more here.
The Pharma Letter
3d
ESMO 2024: Positive Phase II results for Pfizer’s ponsegromab in cancer cachexia
The Phase II study of ponsegromab, a monoclonal antibody directed against growth differentiation factor-15 (GDF-15), met its ...
Business Wire
5d
Pfizer Presents Positive Data from Phase 2 Study of Ponsegromab in Patients with Cancer Cachexia
This release contains forward-looking information about ponsegromab, an investigational monoclonal antibody designed to treat
cachexia
, including its potential benefits and late-stage development ...
2d
Optimistic Buy Rating for Artelo Biosciences Amidst Growing Focus on Cancer Cachexia Therapies
Maxim Group analyst Jason McCarthy maintained a Buy rating on Artelo Biosciences (ARTL – Research Report) yesterday and set a price ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Kentucky judge fatally shot
Makes MLB history
COVID, Wuhan market link
Rally attendees injured
Ban called for in TX schools
Boy kills bear, saves father
To get a second moon
To receive Holbrooke award
NYC subway joyride arrest
30 yrs in prison for assault
US healthcare system falls
160M euros to Ukraine
Gun case sentencing delay
FTC on privacy controls
Retaliated against scientists
Los Angeles dengue cases
Deal to build new arena
UN backs Palestine
Launches AI assistant
EU warns Apple
Joins Motion Picture Assn.
Existing home sales drop
Israel strikes Hezbollah
US jobless claims fall
Man charged for threats
AC mayor, wife indicted
Hails economic progress
Collapse hazard recall
Overdose deaths drop in US
Vows to remain in race
Cancels appearance w/ Duda
Families lose appeal
Dow, S&P hit record highs
Feedback